AI Science Tracker
EN

Loss of CHGA Protein as a Potential Biomarker for Colon Cancer Diagnosis: A Study on Biomarker Discovery by Machine Learning and Confirmation by Immunohistochemistry in Colorectal Cancer Tissue Microarrays

Institute of Medical Sciences, School of Medicine, Örebro University, 702 81 Örebro, Sweden · 27 May 2022 · medicine

Discovery

Loss of CHGA Protein as a Potential Biomarker for Colon Cancer Diagnosis: A Study on Biomarker Discovery by Machine Learning and Confirmation by Immunohistochemistry in Colorectal Cancer Tissue Microarrays

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning screening of protein-interaction candidates selected CHGA as a colorectal-cancer biomarker; the study reports AUC 0.90 in microarray data, 0.995 in RNA-seq data and immunohistochemistry across 198 specimens. This supports a candidate biomarker association, not prospective screening benefit.

Technology: Machine learning screens protein-interaction candidates; CHGA is selected and evaluated in tissue arrays.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine learning screens protein-interaction candidates; CHGA is selected and evaluated in tissue arrays.
Test and result
Results reports AUC 0.90 microarray, 0.995 RNA-seq and IHC across 198 specimens; follow-up is candidate biomarker evidence.
Limitation / still unknown
Evidence supports a candidate biomarker association; prospective screening and clinical outcomes were not tested.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC9179857 · https://pubmed.ncbi.nlm.nih.gov/35681650/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.